15 - Valent Pneumococcal Conjugate Vaccine (VAXNEUVANCE™)
15 - Valent Pneumococcal Conjugate Vaccine (VAXNEUVANCE™)

There are over 100 serotypes of pneumococcus, of which serotype 3 is the biggest threat. Regardless of age, most severe and hospitalised cases of pneumococcal infection are caused by serotype 3. Streptococcus pneumoniae causes a wide range of diseases, including middle ear infection (acute otitis media), pneumonia, and various forms of invasive pneumococcal disease (IPD), such as meningitis and bloodstream infection (bacteremia and sepsis). Pneumococci are commonly found in the nose and throat of healthy individuals, especially children. Transmission occurs primarily through droplets generated by coughing and sneezing, close contact with infected individuals, or contact with contaminated objects. Pneumococcal vaccination is one of the safe and effective means of preventing pneumococcal diseases.

15-Valent Pneumococcal Conjugate Vaccine (VAXNEUVANCE™) is now indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals. VAXNEUVANCE™ specifically targets serotype 3 pneumococcus and helps prevent pneumonia and invasive disease (meningitis, septicaemia, etc.) caused by pneumococcus (including 15 serotypes).

Highlights:

  • According to the recommendation made by the Scientific Committee on Vaccine Preventable Diseases (SCVPD) under the Centre for Health Protection of the Department of Health (DH), VAXNEUVANCE™ induces high immunogenicity against serotype 3 which is believed to be more effective in preventing IPD caused by this serotype.
  • It is approved for use by the US FDA and the EU, and is widely used in European and American countries such as the US, the UK and Canada, as well as Australia.
  • This is a registered pharmaceutical product approved by the Pharmacy and Poisons Board of Hong Kong. It meets the criteria for safety, efficacy, and quality.

How:

  • Intramuscular Injection
  • Single-dose / multiple-doses administration (where applicable)

Recommended for

- Individuals aged 6 weeks or above and under 2 years old:

Standard Regimen* (2 primary doses + 1 booster dose)

  • First primary dose at 2 months of age
  • Second primary dose at 4 months of age
  • One booster dose at 12 months of age

* A catch-up schedule is to be followed for any missed or delayed doses. Please consult a medical practitioner for the applicable schedule of vaccine administration.

- Individuals aged 2 years old or above: Single Dose

Recommended for

Individuals aged 6 weeks or above
Terms & Conditions
  1. Price only includes single dose of 15-Valent Pneumococcal Conjugate Vaccine.
  2. Doctor's consultation is included prior to the first dose of vaccine. If customer is assessed to be not suitable for vaccination, the fee will be refunded subject to a deduction of doctor’s consultation fee at HK$300.
  3. The product is not applicable to Vaccination Subsidy Scheme.
  4. This vaccination service is applicable to individuals aged 6 weeks or above.
  5. Quality HealthCare will contact the customer in around 5 working days after the date of payment for appointment arrangement.
  6. Customers must present their identity cards and order confirmation letter (printed or e-version) on the appointment day for verification.
  7. Each dosage of vaccination will be valid for 6 months starting from the date of payment. Customer must redeem and complete each dosage within the 6 months’ period.
  8. No amendment to the vaccination service ordered is allowed once payment is confirmed. Any fees paid will not be transferable and will not be refundable.
  9. In case of disputes, the decision of Quality HealthCare Medical Services Limited shall be final.
  10. For any enquiries, please call the hotline during our business hours at 8301 8301.

Please enter the designated Corporate Client Privilege Code to discover exclusive privileges

Cancel

Terms & Conditions:

  1. Corporate Client Privilege Code is for QHMS corporate clients only.
  2. Corporate client privilege cannot be used in conjunction with other privileges and cannot be exchanged for cash or other products, resold or used for commercial purposes.
  3. In case of dispute, the decision of Quality HealthCare Medical Services Limited shall be final.